SynthesisJAMA oncology2017

Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non-Small Cell Lung Cancer Trials: A Meta-analysis.

Gideon M Blumenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.